Pliakos , Class of 2022, Rosalind Franklin University of Medicine & Science The Cost-Effectiveness of Cephazolin compared to nafcillin for the treatment of methicillin-sensitive Staphylococcus aureus bacteremia Mentor: Eleftherios Mylonakis, MD, PhD Councilor: Michael Zdon, MD (AA, Rosalind Franklin University of Medicine & Science, 1991) Adrian Rodrigues , Class of 2023, Stanford University School of Medicine Studying the Anti-Tumor Effects of Microglial Depletion and Repopulation in a Murine Glioma Model Mentor: Melanie Hayden-Gephart, MD, MAS Councilor: Suzann Pershing, MD, MS (AA, Medical University of South Carolina College of Medicine, 2005) Diana Rubio , Class of 2021, University of Minnesota Medical School Stroke in Minorities: A Retrospective Observational Study Mentor: Haitham Hussein, MD, MSc Councilor: Charles Billington, MD (AA, University of Kansas School of Medicine, 1978) Michelle Santoso , Class of 2023, University of Tennessee Health Science Center College of Medicine Mitochondria-Containing Extracellular Vesicles Restore Myocardial Bioenergetics Mentor: Phillip C.Yang, MD Councilor: Harris L

Equity concerns with trendy new drugs As the demand for GLP-1 drugs grows and some online companies make it easy for off-label use of the medications, some doctors are concerned about patients having equitable access to the meds
Suddenly stopping these medications may lead to changes in blood sugar levels and appetite regulation
If you lose 40 pounds, for example which is really common with these new drugs you lose about 10 pounds of bone and muscle and 30 pounds of fat, he explains
Food and Drug Administration (FDA) for human consumption or clinical use